.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
AstraZeneca
Medtronic
US Department of Justice
Chubb
Citi
Colorcon
Cipla
Novartis

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075951

« Back to Dashboard
NDA 075951 describes NORETHINDRONE ACETATE, which is a drug marketed by Aurobindo Pharma Ltd, Barr, Amneal Pharms, Mylan Labs Ltd, Glenmark Generics, Barr Labs Inc, Mayne Pharma, and Glenmark Pharms Ltd, and is included in twenty NDAs. It is available from nine suppliers. Additional details are available on the NORETHINDRONE ACETATE profile page.

The generic ingredient in NORETHINDRONE ACETATE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for NDA: 075951

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Pharmacology for NDA: 075951

Ingredient-typeProgesterone Congeners

Suppliers and Packaging for NDA: 075951

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORETHINDRONE ACETATE
norethindrone acetate
TABLET;ORAL 075951 ANDA KAISER FOUNDATION HOSPITALS 0179-1847 0179-1847-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-1847-70)
NORETHINDRONE ACETATE
norethindrone acetate
TABLET;ORAL 075951 ANDA KAISER FOUNDATION HOSPITALS 0179-1847 0179-1847-88 2400 TABLET in 1 BOTTLE (0179-1847-88)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:May 25, 2001TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Julphar
Dow
Cipla
QuintilesIMS
Fuji
Daiichi Sankyo
McKesson
Farmers Insurance
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot